Client Login :: News :: Events :: Investor Relations :: Careers :: Publications :: Ordering
Home :: Site Map :: Contact Us
 
 
Follow Us with Facebook Follow Us with Twitter Follow Us with Youtube Follow Us with Linkedin
  • Patients
    • Symphony Profile
    • About MammaPrint
      • A Woman's Commitment: A test for women, by a woman.
      • Patient Stories
    • Why MammaPrint
      • MammaPrint Patient Brochures
    • Questions & Answers
    • FDA Clearance
    • Getting Your Symphony Profile
    • Symphony Providers
    • Insurance Coverage
      • Questions & Answers
    • Clinical Trials
      • MINDACT
      • MP-90
      • PARSC
    • Awards and Recognition
    • Symphony Outside the US
  • Physicians
    • Symphony Profile
    • MammaPrint
      • Unbiased Science
        • Gene Expression Profiling
        • Microarray Technology
        • RNA Integrity
        • 70 Genes Cover the Metastatic Cascade
        • Developed on Untreated Patients
      • Validation
      • Prognosis & Prediction
      • FDA Clearance
      • Patient Eligibility in the USA
      • Patient Eligibility Internationally
      • Publications & Abstracts
      • Test Results
        • Customer Pages
      • Ordering Symphony
        • Sampling Instructions
        • Order Kits
      • Insurance Coverage
      • Clinical Trials
    • Why MammaPrint
    • BluePrint
      • Validation
      • Results
      • Ordering
    • TargetPrint
      • TargetPrint for ER/PR/HER2
        • Why Gene Expression
      • Validation
      • Results
      • Ordering
    • TheraPrint
    • ColoPrint
      • ColoPrint For Early Stage Colon Cancer Patients
      • ColoPrint Development and Validation
    • Ordering
      • Order Kits
      • Sampling Instructions
    • Customer Pages - Online Login
    • Publications
    • Accreditation and Licenses
    • Clinical Trials
      • MINDACT
        • MINDACT Coordination
        • MINDACT Participating Centers
        • MINDACT Information
      • I-SPY I & II
        • I-SPY II Overview
        • I-SPY II Participating Centers
      • MP-90
      • PARSC
        • PARSC Coordination
        • PARSC Participating Cancer Centers
      • Locations
      • Contacts
    • Research
    • Insurance Coverage
      • FAQ's
      • Agendia Cares Commitment
  • About Us
    • Mission
    • History
    • Leadership
      • Executive Management
      • Supervisory Board
      • Medical & Scientific Advisory Board
    • Awards and Recognition
    • News
    • Events
    • Strategic Alliances
    • Investor Relations
    • Careers
      • Current Postings in USA
      • Current Postings in Nederland
    • Contact Us
 
  • Symphony Profile
  • MammaPrint
    • Unbiased Science
      • Gene Expression Profiling
      • Microarray Technology
      • RNA Integrity
      • 70 Genes Cover the Metastatic Cascade
      • Developed on Untreated Patients
    • Validation
    • Prognosis & Prediction
    • FDA Clearance
    • Patient Eligibility in the USA
    • Patient Eligibility Internationally
    • Publications & Abstracts
    • Test Results
      • Customer Pages
    • Ordering Symphony
      • Sampling Instructions
      • Order Kits
    • Insurance Coverage
    • Clinical Trials
  • Why MammaPrint
  • BluePrint
    • Validation
    • Results
    • Ordering
  • TargetPrint
    • TargetPrint for ER/PR/HER2
      • Why Gene Expression
    • Validation
    • Results
    • Ordering
  • TheraPrint
  • ColoPrint
    • ColoPrint For Early Stage Colon Cancer Patients
    • ColoPrint Development and Validation
  • Ordering
    • Order Kits
    • Sampling Instructions
  • Customer Pages - Online Login
  • Publications
  • Accreditation and Licenses
  • Clinical Trials
    • MINDACT
      • MINDACT Coordination
      • MINDACT Participating Centers
      • MINDACT Information
    • I-SPY I & II
      • I-SPY II Overview
      • I-SPY II Participating Centers
    • MP-90
    • PARSC
      • PARSC Coordination
      • PARSC Participating Cancer Centers
    • Locations
    • Contacts
  • Research
  • Insurance Coverage
    • FAQ's
    • Agendia Cares Commitment

ColoPrint® Development and Validation


ColoPrint is currently in the validation stage.  Agendia is actively engaging academic centers and medical institutions throughout the USA and internationally to participate in the PARSC clinical trial.

For more information about participation in the PARSC trial, please visit the PARSC Clinical Trial for Colon Cancer page.

 

 
 
Patients :: Physicians :: About Us :: Login :: News :: Events :: Investor Relations :: Careers :: Publications :: Ordering :: Home :: Site Map :: Contact Us
© Agendia 2009-2011 | Recommendation | Terms of use | Legal notices | Privacy Policy